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a b s t r a c t
Features of human rhinovirus (RV)-C virions that allow them to use novel cell receptors and evade
immune responses are unknown. Unlike the RV-AþB, these isolates cannot be propagated in typical
culture systems or grown for structure studies. Comparative sequencing, I-TASSER, MODELLER, ROBETTA,
and reﬁned alignment techniques led to a structural approximation for C15 virions, based on the
extensive, resolved RV-AþB datasets. The model predicts that all RV-C VP1 proteins are shorter by 21
residues relative to the RV-A, and 35 residues relative to the RV-B, effectively shaving the RV 5-fold
plateau from the particle. There are major alterations in VP1 neutralizing epitopes and the structural
determinants for ICAM-1 and LDLR receptors. The VP2 and VP3 elements are similar among all RV, but
the loss of sequence “words” contributing Nim1ab has increased the apparent selective pressure among
the RV-C to ﬁx mutations elsewhere in the VP1, creating a possible compensatory epitope.
& 2013 Elsevier Inc. All rights reserved.
Introduction
The human rhinoviruses (RV) comprise 3 species, RV-A, RV-B
and RV-C, in the Enterovirus genus of the Picornaviridae
(Palmenberg et al., 2009). Collectively, these positive sense RNA
viruses are the most frequent cause of the common cold. Between
50 and 85% of asthma exacerbations are due to RV infections (Gern
and Busse 1999; Hayden 2004; Dougherty and Fahy 2009) and RV-
induced wheezing illness in infants corresponds with a high risk of
developing childhood asthma (Jackson et al., 2008). Many infec-
tious properties of the RV link directly to their virion structures.
Like all picornaviruses, the capsids are icosahedral (pseudo-T¼3),
composed of 60 copies each of four structural proteins, VP1, VP2,
VP3 and VP4. The three largest proteins, VP1-3, assume similar
8-stranded, anti-parallel β-barrel motifs, despite being formed
from very different sequences (Fig. 1). Protomer units of VP1-4
are derived from a common polyprotein precursor. Assembly is
nucleated around the RNA during infection into particles with
5-fold, 3-fold and 2-fold axes of symmetry. The shapes and surface
extensions inherent to individual VP1-3 confer strain-speciﬁc
properties of immunogenicity, receptor binding and drug suscept-
ibility to each RV isolate. The short VP4 proteins, cleaved from
intermediate precursor VP0, become myristoylated (N-terminus)
as an assembly prerequisite, and ultimately localize with protomer
symmetry, inside the capsid, adjacent to the packaged RNA.
The 99 original serotypes of RV-AþB were deﬁned by immu-
nogenic cross-reactivity (Kapikian 1967). But now more routinely,
related isolates from all 3 species are binned as “genotypes” if their
VP1 nucleotide relationships exceed 87% identity (Simmonds et al.,
2010; McIntyre et al., 2013). The RV-A (79 types) and RV-B (30
types) are well studied at the structural and clinical levels. All
these utilize either ICAM-1 (98 “major” types) or LDLR (11 “minor”
types) as their cellular receptors. The molecular nuances of these
interactions have been described by co-crystallization and EM
studies. The RV-AþB that make up the major and minor groups
conserve surface footprints that explain how and why particular
isolates use their respective receptors to interact with cells
(Bochkov et al., 2011).
In 2006 the discovery of a new RV species surprised the
molecular and clinical communities. The RV-C are clearly rhino-
viruses, but unlike RV-AþB, they are not readily propagated in
typical cell culture systems, including WI-38, WisL, BEAS-2B, A549
and HeLa lines (Bochkov et al., 2011). The 51 recognized RV-C
types (as binned by sequence analysis) were identiﬁed by PCR
while ﬁshing through patient samples for other RV. The new
isolates have special clinical relevance since it is now recognized
that the RV-C are associated with up to half of infections in young
children (Bochkov et al., 2011; Lee et al., 2012). They grow readily
in both the lower and upper airways, tolerate higher growth
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temperatures (Ashraf et al., 2013) and use cell receptors not
common to the RV-AþB (Bochkov et al., 2011). Complicated
procedures have ampliﬁed some RV-C in mucosal organ cultures,
but this technique is difﬁcult and requires primary human donor
samples (Bochkov et al., 2011). Parallel work with air–liquid
interface (ALI) cultures is promising (Ashraf et al., 2013; Hao
et al., 2012), but neither technique has yet produced enough virus
for extensive biological or structural studies. Instead, RV-C infor-
mation is projected by comparative sequencing. There are now full
or nearly full genome datasets from 68 isolates, with deeper
information for the VP1 protein (300 additional seqs). The
genome of rhinovirus C15 (strain W10), an early isolate, was
cloned into cDNA, and the resulting transcripts proved infectious
to HeLa cells (Bochkov et al., 2011). Consequent inhibition assays
with this (albeit low titer) virus showed that ICAM-1 and LDLR
antibodies failed to prevent C15 from attaching to cells. This
conﬁrmed that the RV-C use unique receptor(s) (Bochkov et al.,
2011), although their basic biology is similar to other RV. Identi-
ﬁcation of this new receptor(s) is hampered by the lack of primary
organ cultures and inconsistencies among donor samples. The
same problems make antiviral tests difﬁcult.
To gain more insight into the RV-C, we turned to computational
structure prediction methods. Homology, protein threading and ab
initio modeling are three kinds of these applications. Homology
modeling uses sequence identity from robust alignments to search
determined structures for likely homologs. Threading does not
require outside sequences, but best-ﬁts a protein to a database of
known structure templates. Ab initio relies neither on homologs or
existing structures and instead computes the lowest energy con-
formation(s) inherent to given protein. Multiple isolate determina-
tions of full-length RNA genomes, representing 141 RV types, have
been sequenced and aligned (Palmenberg et al., 2009). There are
atomic resolution structures for A1, A2, B3, B14 and A16 protomers,
along with numerous derivatives embodying capsid mutations and
drug-bound complexes. The extensive data cohort was ideal for
homology (MODELLER, ROBETTA) and threading methods (I-TASSER)
when applied to predictions of the C15 capsid. As reported here, the
strength of these techniques, backed by deep, reﬁned alignments of
all known rhinovirus isolates, allowed construction of a highly
predictive model that can guide antiviral drug targeting as well as
receptor discovery until an actual RV-C structure is resolved experi-
mentally. The data converge on the ﬁnding that all RV-C have major,
conserved deletions in the VP1 protein, shaving signiﬁcant mass
from the 5-fold virion plateau, altering the canyon and immunogenic
proﬁles, and presenting novel receptor interfaces and chimeric
hydrophobic pockets for drug binding.
Results and discussion
C15 model development
I-TASSER implements multiple threading algorithms and itera-
tive structure assembly simulations to ﬁnd optimal sub-fragments
within a database of structures or within a user-speciﬁed structure
(Zhang 2008; Roy et al., 2010). Full-length models are assembled
by excising fragments using replica-exchange Monte Carlo simula-
tions. The functions and ligands are inferred with a ﬁnal structure–
structure alignment program. Outputs consistently score well in
CASP competitions (Battey et al., 2007; Zhang, 2007, 2009;
Cozzetto et al., 2009).
C15 was chosen to represent this species because an isolate
(W10) was cloned into infectious cDNA and was available as virus
to test predictions (Bochkov et al., 2011). The C15 VP1-4 share 77%
amino acid identity and equivalent indels among all known RV-C
(consensus sequence). The respective proteins of 278, 265, 235,
and 67 amino acids were assessed independently against the full I-
TASSER database, including the known set of all determined
picornavirus structures. The program picked A16 as the statisti-
cally best model for all VP1-3 sub-fragments (not shown). To
reﬁne this assessment, A16 and B14 ﬁles, with and without bound
pleconaril as part of the structures, were resubmitted as speciﬁed
templates. Each output (VP1-3) was evaluated according to
I-TASSER metrics (Zhang 2008; Roy et al., 2010). Again, native A16
(1aym) had the highest scoring conﬁdence levels (C-score), and TM-
scores, with RMSD relative to C15, in the 2–3 Å range (Table 1).
Given that C15 and A16 share only 44–59% amino acid identity
throughout their capsids (discounting indels) these are exception-
ally good structure ﬁts. All PDB depositions for the RV, especially for
A16 and B14, register large portions of the VP4 sequence as
disordered. I-TASSER was able to extrapolate a complete C15 VP4
only by using other enterovirus templates. Therefore, this portion of
the model is clearly of lower quality (Table 1).
To evaluate whether similar results would be obtained by other
prediction methods, the VP1-4 of C15 was submitted to MODELLER
(Sali and Blundell 1993). This homology modeling program begins
with a pairwise input alignment and calculates an initio model
containing all likely non-hydrogen atoms that satisfy a spatial
restraints methodology. Then, estimates of loops are calculated de
novo, or relative to the input template if there is reasonable
similarity. Regardless of the selected template (A16 and B14, with
or without pleconaril) the resultant C15 models looked similar to
each other and each scored well according to internal benchmarks
(not shown). The VP1 C15 sequence was also submitted to ROBETTA
Fig. 1. RV capsid arrangement. (A) Particles have 60 crystallographic subunits with VP1 (blue), VP2 (green) and VP3 (red) and VP4 (internal) proteins arranged in icosahedral
symmetry. (B) A canyon-like depression circles each 5-fold axis from which a hydrophobic drug-binding pocket extends into the interior of each VP1. (C) Subunit ribbon
diagram of A16 shows protein contributions to the north and south walls of the canyon. A biological assembly protomer would include this VP1, a VP2þ4 precursor (VP0),
and the VP3 from the adjacent (clockwise) crystallographic subunit. Figure modeled after (Hadﬁeld et al., 1995).
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(Kim et al., 2004), another online suite that combines “template-
based” homology modeling with ab initio methods. Again, from
among all possible homologs, the program selected A16 (1aym) as
the preferred template. The I-TASSER, MODELLER and ROBETTA
results were aligned to each other using MAMMOTH (Ortiz et al.,
2002) or the MAMMOTH-multi suit (Lupyan et al., 2005). Among all
outputs, there was 94–96% agreement for the C15 VP1 (Table 2)
indicating strong similarity regardless of algorithm. However, since
I-TASSER predicted the entire capsid length, albeit with tentative
veracity for VP4, subsequent analyses were based on those predic-
tions. That is, an I-TASSER model of C15 relative to A16 for VP1-3,
and relative to the whole I-TASSER database for VP4.
The preferred model was then evaluated by ProQ, a structure
quality predictor (Wallner and Elofsson 2003). It scored in the
“extremely good” range (5.287) for the LGscore, and in the “fairly
good” range for the MaxSub (0.361). As benchmarks for these
values, parallel submission of the A16 parent (1aym) as resolved to
2.15 Å resolution, also scored “extremely good” for LGscore (5.998)
and “fairly good” (0.44) for MaxSub. The projected C15 stereo-
chemistry was checked for feasibility with PROCHECK, part of the
PDBSum program suite (Laskowski et al., 1993). Calculations for
the main-chains of the model showed key parameters (bad non-
bonded interactions, C-α tetrahedral distortion, hydrogen bond
energy and overall G-factor) to be within the normal range for a
typical 2 Å resolution structure. Ramachandran plot quality assess-
ment reﬂects a structure with between 2.5 and 3.0 Å resolution
and the peptide bond planarity was above the normal range
(3–81 standard deviation) at around 111. The side chain
properties were all “normal” (or “better”) relative to a typical 2 Å
resolution structure. The tested parameters included standard devia-
tion of the chi-1 gauche minus torsion angles, standard deviation of
the chi-1 trans torsion angles, standard deviation of the chi-1 gauche
plus torsion angles, pooled standard deviation of all chi-1 torsion
angles and standard deviation of the chi-2 trans torsion angles.
Therefore, the selected model is strong and feasible. Apart from VP4,
which remains unresolved inmost datasets, it is highly consistent with
measurable parameters of experimentally determined RV. Proteins for
A16 and C15 (model) are shown in Fig. 2. The orientation and shapes
of the β-barrels are almost indistinguishable.
Topography of the C15 model
Genome alignments are available for many enteroviruses, and are
especially deep for isolates in the RV species (Palmenberg et al., 2009).
The alignments were founded on superimposition of known struc-
tures, particularly for the capsid regions and therefore, analogy
Table 1
C15 I-TASSER conﬁdence scores.
% Identitya % Alignedb RMSDc E-valuec Z-scorec  ln(E)c
VP1 44 95.34 1.4 2.65E-14 35.53 31.26
VP2 59 94.34 1.84 7.28E-14 31.86 30.25
VP3 45 99.57 0.79 1.92E-13 30.82 29.28
VP4 62 43.94 3.09 6.15E-02 2.49 2.79
a Percent pairwise amino acid identity between A16 and C15.
b MAMMOTH (Ortiz et al., 2002) evaluated C15 output PDB ﬁles from I-TASSER
and MODELLER as in Methods. “aligned” is the % of residues with common C-α
backbone coordinates (o4 Å) in both models.
c Comparative output values for each protein are indicated. “RMSD” is root-
mean-square deviation (in angstroms).
Table 2
I-TASSER, MODELLER and ROBETTA comparison.
MAMMOTHa VP % Aligneda RMSDb E-valueb Z-scoreb  ln(E)b
ITAS vs MOD 1 95.34 1.4 2.65E-14 35.53 31.26
ITAS vs MOD 2 94.34 1.84 7.28E-14 31.86 30.25
ITAS vs MOD 3 99.57 0.79 1.92E-13 30.82 29.28
ITAS vs MOD 4 43.94 3.09 6.15E-02 2.49 2.79
MAMMOTH-multc VP % Aligneda RMSDb E-valueb Z-scoreb  ln(P)b
A16 vs ITAS 1 92.09 1.91 0.6E-13 32.15 30.52
A16 vs MOD 1 92.09 1.90 0.6E-13 32.15 30.52
A16 vs Rob 1 91.01 3.10 0.8E-13 31.73 30.13
ITAS vs MOD 1 95.68 1.40 0.2E-13 33.53 33.53
ITAS vs Rob 1 93.53 2.84 0.3E-13 32.70 31.04
MOD vs Rob 1 94.96 2.69 0.2E-13 33.25 33.25
a MAMMOTH (Ortiz et al., 2002) evaluated C15 output PDB ﬁles from I-TASSER
(ITAS) and MODELLER (MOD) as in Methods. “Aligned” is the % of residues with
common C-α backbone coordinates (o4 Å) in paired structures.
b Comparative output values for each protein are indicated. “RMSD” is root-
mean-square deviation (Å).
c MAMMOTH-mult (Lupyan et al., 2005) evaluated VP1 PDB ﬁles from A16
(1aym) and C15 VP1 models generated by ITAS, MOD and Robetta (Rob).
Fig. 2. Structure comparison. Ribbon diagrams for A16 (gray) and C15 (blue, green,
yellow, red; models) are labeled with features, using the nomenclature of
(Rossmann et al., 1985). The structures were formatted, oriented and rendered in
MacPyMOL (The PyMOL Molecular Graphics System 2008).
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(same function) and homology (same lineage) are clearly predicted.
Indeed, within every viral protein, including VP1-4, there are bench-
mark residues that unambiguously delineate every internal β or α
element. Among the RV, large relative indels are rare. Outside of VP1
and a few discontinuities that are potential sequencing errors (e.g. C19
EU840728), the only serious length variance is at the N-terminus of
the 3A protein, where the RV-B are longer than the RV-A (2–3 aa) and
the RV-C (9 aa).
Given this conservation, the VP1 indels are striking. The
β-barrel cores superimpose, but the collective βB-βC, βD-βE and
βH-βI loops of all RV-C are shorter by 22 aa relative to the RV-A,
and 28 aa relative to the RV-B. For C15 speciﬁcally, the βB–βC
loop is 10 aa shorter than A16 and 13 aa shorter than B14 (Fig. 3).
The corresponding βD–βE loops are 8 and 10 aa shorter. The βH-βI
loops are 4 aa shorter. As these elements supply virtually all of the
mass to the 5-fold virion plateau, the C15 model predicts the
capsid surface must change radically. Full reconstructions (Fig. 4A,
Fig. 6E) and “roadmap” topographic projections (Fig. 4B) highlight
the impact. Relative to A16, B14 and every other resolved enter-
ovirus structure (61 in the PDB) the 5-fold plateau of C15 is
effectively gone. In its place, the missing mass is so severe as to
cause a depression rather than a projection at the 5-fold. Depth-
cued cross-sections measure the loss at up to 20 Å in plateau
height (Fig. 4C). Because of poorly resolved VP4 in existing
structures it cannot be anticipated whether this “shaving” creates
an overall thinner protein shell at the 5 fold, but most certainly it
creates a different physical surface over at least 1/3 of the particle,
including all territory “north” of the canyon.
The “south wall” of the C15 canyon, in contrast, and including
the 2-fold and 3-fold regions, is more similar to A16 and B14. Side-
by-side (Fig. 2), it is hard to identify VP2-3 differences that overtly
affect the mass or orientation of a β, α or loop element. Among all
RV (N¼349), the longest VP2-3 indels are just 1–2 aa, and these
tend to be type-, rather than species-speciﬁc (Fig. 3). The canyon
itself is maintained, as evidenced by the depression (blue) in the
center of each roadmap icosahedral unit (crystallographic sub-
unit). Additional shallow residues extend north-west and north-
east of the central depression, ringing around the 5-fold and
completing the canyon (Fig. 4B). All 3 viruses have secondary
depressions in the 2-fold region. This interface is formed by VP1
and VP3 interactions with contributions from the N-terminus of
VP2 (Reisdorph et al., 2003). As there are no indels covering any
interface residues, and strong conservation at the sequence level,
the C15 model preserves all relevant contacts at both the 2-fold
and 3-fold. It should be noted though, that the structure ﬁles for
A16 and B14 are missing the N-terminus of VP2 (8–9 aa) and up to
half of VP4 (29–40 aa). If the respective surfaces were to be
inﬂuenced by inclusion of these full proteins, it is not apparent
from roadmaps.
C15 surface residues
Virion surfaces are under evolutionary pressure for immuno-
logical diversity and receptor binding. The charge distributions for
A16 or B14 are typical of their species (Fig. 5A,C). Uncharged or
mildly polar (yellow: Asn, Gln, Ser and Thr) residues cluster
around the 3-fold region, while the 2-fold conserves acid (red:
Asp, Glu) and basic (blue: Arg, Lys, His) patches. The north wall of
the canyon, edging the plateau, is strongly charged, contributing
contacts for ICAM-1 and LDLR. Receptor footprint conservation
within the RV-AþB is well described (Kolatkar et al., 1999; Hewat
et al., 2000), as is the lack of conservation of these same residues
in an alignment of RV-C (Bochkov et al., 2011). The C15 model not
only emphasizes the truncation of the required receptor binding
sites (i.e. VP1 βB–βC loop), it shows that the residual VP1 sequence
(s) display a very different charge pattern in addition to new
topography (Fig. 5E). The depression at the 5-fold for all RV-C is
anchored with a basic His or Lys (VP1-161) then rimmed with
uncharged amino acids in a pattern dissimilar to RV-AþB. Many of
these newly exposed VP1 residues are conserved in every RV-C
(Fig. 5F, black), or present in 490% of the known sequences (dark
gray). The model and the alignments converge on the idea of a
unique receptor footprint, similar among all RV-C, and likely to
map around the unusual shaved VP1 conﬁguration at the 5-fold.
RV-C immunogenicity
Neutralizing immunogenic sites (Nims) for B14 were originally
identiﬁed in an historic study correlating the structure of the
particle with monoclonal antibody escape mutations (Sherry et al.,
1986). Continuous and discontinuous epitopes take their names
from the VP contributing the dominant surface loop (Fig. 6A,B).
Nim1a and Nim1b include fragments of the VP1 βB–βC and βH–βI
loops. Nim2 pairs the βE–αB “puff” loops of VP2 with the βG–βH
“FMDV” segment of VP1. Nim3 is formed by an insertion in the βB of
VP3, with contributions from the βB–βC loop and the nearby VP1
COOH tail (Rossmann et al., 1985). Not surprisingly, in all resolved
Fig. 3. Core structure elements. The VP1-3 sequences for A16, B14 and C15 are illustrated to scale showing the color-coded locations of α and β segments using the
nomenclature of (Rossmann et al., 1985). The A16 and B14 elements are according to determined structures. The C15 elements are inferred by analogy in sequence
alignments. B14 loops encoding neutralization escape mutations (Nim) are highlighted as are key, relative C15 deletions in VP1 (e.g. Δ13).
H.A. Basta et al. / Virology 448 (2014) 176–184 179
RV structures these regions display as raised features (Fig. 6C,D),
allowing antibody contact without compromising the underlying
core, the canyon, or receptor binding motifs. In C15, the physical
loops for putative Nim2 and Nim3 analogs are similar to A16 and
B14 (e.g. Fig. 3). But the VP1 loops that would present Nim1a and
Nim1b are removed by the species-wide deletions (Fig. 6C).
Experimentally, the immunogenicity for any RV-C is unknown
and the typing of current isolates is based solely on full-length VP1
pairwise identities. However, as the alignments contain multiple
representatives of each RV-AþB; it is possible to record how loop
sequences vary for known serotypes, and by inference, to extra-
polate potential epitopes for the RV-C. Statistical screening
depends on the concept that immunogenic sites ﬁx mutations
more readily than the genome as a whole. But given that 141 RV
types are already deﬁned, the formative selective pressures cannot
be subtle. The alignment segments encoding VP1-3 surface ele-
ments were queried for the number of unique sequence “words”
observed among the isolates (Table 3). For the RV-AþB in the
mapped Nim sites, the sequence variability (observed words) was
frequently greater than the number of types within the species.
For example, the Nim2(b) loop residues 2155–2167 in VP2
record116 sequence variants among 79 types of RV-A. In the RV-
B, there are 37 variants within 30 types. Many of these added
sequences, however, co-vary within a single type, so that overall,
about 93–96% of the measured words are unique to a given type,
and predictive of it. The Nim-type predictions showed consistent
values of 85–98% among the measured RV-AþB surface loop
segments regardless of which Nim was queried. As expected,
regions that are not under immune selection, ﬁx mutations at
lower frequencies. Fewer words (10–12) and lower type-
correlations (64–77%) were observed in words from a core β
segment (e.g. VP1 βG) or from a non-capsid region of the 3D pol.
Here, multiple types frequently share the same sequence words.
For perspective, 61% of all RV-A alignment positions and 66% of all
RV-B alignment positions share 490% aa identity within their
species, regardless of whether the residues are averaged from the
P1 (capsid) or P23 (non-structural) regions.
The RV-C are less well conserved. Only 48% and 51% of the
alignment positions share 490% identity among the P1 and P23
proteins as a whole, respectively. But in the putative Nim2 and
Nim3 sites, including the VP1 and VP2 COOH ends (also on the C15
surface), the correlation with type was 94–97%. These high values
suggest the compared words are legacies of strong evolutionary
lineages, presumably immunologic, among all RV-C isolates. If
true, it means the raised VP2 and VP3 surface topographies (Fig. 4,
Fig. 6E) are likely to be authentic Nims for the RV-C. Moreover,
recombination in the P1 region must be an infrequent means of
epitope swapping because the diverse RV-C surface segments
Fig. 4. Surface topography. (A) Protomer PDB ﬁles for A14, B14 and C15 (model) were extrapolated to full icosahedral capsids using UCSF Chimera (Pettersen et al., 2004). The
color scale illustrates the particle radius, spanning 130 Å (blue) to 165 Å (orange). (B) In parallel, radially depth-cued “roadmaps” show the surface topographies for
respective crystallographic subunits as calculated by RIVEM (Xiao and Rossmann 2007). The applied color scale is the same as A. (C). Cross sections of the particles in A,
through equivalent 5-fold axes, compare the protein depths of the canyon region and 5-fold plateau. The structures were aligned, displayed and rendered using UCSF
Chimera (Pettersen et al., 2004).
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seem to hold true to type, as assigned through the VP1 as a whole.
Surprisingly though, the type-speciﬁc word conservation also held
true for the RV-C VP1 βG–βH loop, a surface segment contributing
to the south wall of the canyon (Fig. 2). In aphthoviruses and
cardioviruses, which do not have canyon features, this “FMDV
loop” is a dominant, continuous, immunogen (Thomas et al., 1988;
Boege et al., 1991). In the RV-AþB, it is much less so. Relative to
the other Nims, there are fewer words observed here among the
RV-AþB isolates and lower covariance with type (Table 3). Only a
single βG–βH residue (B14 1210) has been identiﬁed with antibody
escape mutations (Sherry et al., 1986). For these species, immuno-
genic access to this segment is limited by the steep north wall of
the canyon (Rossmann and Palmenberg 1988). The RV-C however,
vary this region equivalently to other surface loops, and for 98% of
the isolates, the speciﬁc sequence is predictive of type. In contrast
to the RV-AþB structures, the C15 model anticipates the shaved 5-
fold region should expose more of this surface (Fig. 6E), thereby
strengthening selective pressure to ﬁx mutations as a variable
immunogen. The enhanced RV-C epitope potential is recorded in
the βG–βH words and may reﬂect a degree of compensation for
the structural loss of Nim1a and Nim1b. If this is a continuous,
exposed surface epitope, as predicted by the model, antibodies to
the segment should neutralize RV-C, perhaps more potently than
for the equivalent RV-AþB segments.
Insights into RV disease
Isolates in RV-C species are clearly linked to more childhood
illnesses involving lower airways than the other RV (Lee et al.,
2012; Bizzintino et al., 2011). As a rule, the RV-B tend to limit their
replication to sinus tissues and the upper airways, and the
majority of RV-AþB are sensitive to culture temperatures above
33–35 1C (Stott and Heath 1970). The RV-C readily infect upper and
lower airways and are stable to growth at 37 1C (Ashraf et al.,
2013), a property that is capsid-dependent. The lower airway
infections by these viruses can be severe, accounting for the
Fig. 5. Surface character. (A,C,E) Roadmap (Xiao and Rossmann 2007) surface depictions for A16, B14 and C15 are color-coded by amino acid types. The color bins include,
acidic (Asp, Glu), polar (Asn, Gln, Ser and Thr), neutral (Ala, Cys, Ile, Gly, Leu, Met, Phe, Pro, Trp, Tyr and Val) and basic (Arg, His and Lys) residues. (B,D,F) Similar roadmaps
depict species surface residue conservation. Capsid alignment positions were queried for conservation (% amino acid identity) relative to each species' consensus sequence.
The observed identity, encoded in continuous grayscale (black¼100% conserved, white¼0% conserved), is superimposed on the A16, B14 and C15 residue positions.
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majority of asthma attacks resulting in children's hospitalization
(Bizzintino et al., 2011). The profound structure changes in the
5-fold region, predicted by the C15 model necessitate a receptor
preference that is not shared by the RV-AþB and preferred growth
locale could be part of this. But these same changes could easily
make the capsid more stable and less ﬂexible, allowing replication
at higher temperatures.
Materials and methods
Sequences and Alignments
Reﬁned alignments (349 seqs) of complete genome RV RNA
sequences are based on foundation superimposition of determined
structures as described (Palmenberg et al., 2009). Clustal and proﬁle
ﬁts added to this base all recent genome length (i.e. 46000 base) RV
isolates available from GenBank. Placement required every indel to
maximize identity within RV types and species. A translated poly-
protein alignment with species, type and accession numbers is
available in *.meg and *.fasta formats from http://virology.wisc.edu/
acp/aligns/. The set includes RV-A (79 types, 208 seqs), RV-B (30 types,
74 seqs), RV-C (32 types, 67 seqs), and EV outgroups (4 species, 10
seqs). A subset alignment with just VP1 proteins was extracted then
augmented with an additional 500 RV-AþBþC datasets, ensuring
representation for the 51 known types of RV-C, and adding depth to
the RV-AþB within this gene. Current RV nomenclature (McIntyre
et al., 2013) designates the species letter (A, B or C), and type number
(e.g. A16). Strain designations are unique to each accession number.
Fig. 6. Immunogenic sites. (A) A B14 (4rhv) biological protomer highlights residues mapped with escape mutations to a panel of neutralizing monoclonal antibodies, as
deﬁned by (Sherry et al., 1986). (B) The neutralizing immunogenic sites (Nims) cluster on the virion surface (intense colored residues) as part of continuous surface loops
(strong outlines). The Nim2 and Nim3 epitopes are partially discontinuous with contributions from VP1 (blue) and non-adjacent segments of VP2 (green) and VP3 (red).
These loops deﬁne the sequence fragments queried for Nim conservation in Table 3. (C–E) A16, B14 and C15 particles were rendered as in Fig. 4 except that color was
assigned by protein type (as in B) and a semi-transparent sphere was added, masking the topography below a cutoff of 155 Å. The remaining brightly colored features mark
residues above this height, and for B14, include all mapped Nim escape mutation sites.
Table 3
Surface sequence variation vs isolate type.
Segment Observed sequence
“words” a
“Words” predict RV type
b
B14 residues
RV-Ac RV-Bd RV-Ce RV-Ac RV-Bd RV-Ce
VP2 Nim2(a) 2135–2143 115 21 32 85% 80% 94%
VP2 Nim2(b) 2155–2167 116 38 38 96% 93% 97%
VP3 Nim3(a) 3055–3064 106 36 36 92% 96% 97%
VP3 Nim3(b) 3071–3079 103 31 35 98% 95% 95%
VP3 COOH 3227–3236 68 15 36 95% 82% 94%
VP1 Nim1ab 1083–1095 115 43 0 90% 83% (deletion)
VP1 Nim1a 1135–1144 76 33 6f 85% 95% 61%f
VP1 βG 1186–1198 12 10 7 66% 68% 62%
VP1 βG-βH 1205–1212 77 22 36 90% 77% 98%
VP1 COOH 1279–1289 113 39 38 86% 93% 95%
3D-pol 318–331 10 12 21 64% 72% 76%
a Unique sequences (words) in same alignment segment.
b Words conserved within, but not between types (percent).
c 208 isolates, 79 types.
d 74 isolates, 30 types.
e 67 isolates, 32 types.
f 7 of 10 residues deleted.
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I-TASSER
The I-TASSER threading method and online web site (http://
http://zhanglab.ccmb.med.umich.edu/I-TASSER/) have been pub-
lished (Zhang 2008; Roy et al., 2010). The VP1-4 protein sequences
of C15 strain W10 (GQ323774) were extracted into separate ﬁles.
The VP1 was threaded in runs against: the entire I-TASSER
template database (a subset of Protein Databank); A16 (PDB
ID:1aym); A16 with pleconaril (1ncr); B14 (4rhv); and B14 with
pleconaril (1ncq). The VP2 and VP3 sequences were threaded
against A16. The VP4 was threaded against the full template
database. C-score, TM-score and RMSD were recorded for each
model (Table 1). A biological protomer was constructed by super-
imposing the selected C15 models on their A16 (1aym) homologs
using the alignment function of MacPyMOL (The PyMOL Molecular
Graphics System 2008). The orientations were exported then
concatenated manually into a single PDB ﬁle. Helix and sheet
lengths (Fig. 3) were predicted relative to known elements in the
reﬁned alignments.
MODELLER
Independent C15 protomer models (VP1-4) were calculated
(locally on a MacBookPro) using MODELLER version 9v8 (Sali and
Blundell 1993), according to templates, 1aym (A16), 1ncr (A16 plus
pleconaril) and 1ncq (B14 plus pleconaril). For each run, the
complete protomer sequence was aligned against C15 with the
“align2d” and heteroatoms (e.g. pleconaril) were accounted for.
Each output included ﬁve different iterations, which were then
compared to the source template with the “discrete optimized
protein energy” algorithm “DOPE” (Shen and Sali 2006).
ROBETTA
The C15 VP1 sequence was submitted to the Robetta server
(http://robetta.bakerlab.org/) for Ginzu domain prediction using
default settings (Kim et al., 2004). A full 3D prediction was
requested.
MODEL EVALUATION
The PDB ﬁle for the preferred I-TASSER C15 protomer model
was submitted relative to the MODELLER protomer to MAMMOTH
(MAtching Molecular Models Obtained from THeory) (Ortiz et al.,
2002), for plausibility analyses as implemented with the online
web site (http://predictioncenter.org). Using standard parameters,
the suite aligns input structures, calculates the optimal local
similarity of the protein backbone, and then ﬁlls in the residues.
The outputs are scored based on this alignment (percent of
residues aligned, RMSD, E-value, Z-score and –ln(E)). ProQ
(Wallner and Elofsson 2003) was also run online (http://www.
sbc.su.se/bjornw/ProQ/ProQ.cgi). It is a neural-network-based
program that predicts the quality of a model or determined
structure by extracting features (i.e. atom–atom contacts), evalu-
ating their plausibility, and assigning scoring functions LGscore
and MaxSub. The C15 VP1 PDB ﬁles from I-TASSER, MODELLER and
ROBETTA were also compared to each other and to native A16
(1aym) using MAMMOTH-multi (Lupyan et al., 2005), in similar
procedures (http://ub.cbm.uam.es/servers/mammoth/mammoth
mult.php). The sterochemical quality of C15 (I-TASSER) was also
gaged with PROCHECK, part of the PDBSum suite as available
online (http://www.ebi.ac.uk/pdbsum/) (Laskowski et al., 1993).
The coordinates were reﬁned for steric clashes (between and
within putative protomers) with CHIRON (Ramachandran et al.,
2011). Protomer and virion coordinates for the full, preferred C15
model are available from VIPERdb (http://viperdb.scripps.edu/)
using the accession code: hrvc.
Molecular graphics
Protomer illustrations were oriented and rendered in MacPy-
MOL (The PyMOL Molecular Graphics System, 2008). UCSF Chi-
mera (Pettersen et al., 2004) created full capsid structures and
pentameric assemblies from protomer PDB ﬁles. Virion surface
“roadmaps” displaying 3D topographies used the Radial Interpre-
tation of Viral Electron Density Maps (RIVEM) program. RIVEM
illustrates residues occupying the surface of a virus by reading
standard PDB coordinates and plotting them onto stereographic
spheres (Xiao and Rossmann 2007). For comparative roadmaps,
A16 (1aym), B14 (4rhv) and C15 (model), protomer ﬁles were
aligned to “standard Rossmann” (Rossmann et al., 1985) orienta-
tion. The HOH ATOM lines were removed in MacPyMOL. The
amino acids were renumbered into standard “picornavirus format”
identifying the protein chain and sequence position (e.g. residue
1 of VP1 becomes 1001, residue 1 of VP2 is 2001, etc.). RIVEM (run
locally in LINUX CENTOS 5, 32 bit) then created radial coordinate
surface maps with matching color scales according to virion radii
(Fig. 4B). User speciﬁed properties such as residue charge, hydro-
phobicity, chain identity (e.g. Fig. 5A,C,E) can be selected within
the program. Roadmaps showing sequence conservation used PDB
ﬁles with % identity embedded in the B-factor column, according
to the residue-speciﬁc values calculated from the full, reﬁned
alignments.
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